Ruba Ghalayni

ORCID: 0009-0004-3942-0173
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pulmonary Hypertension Research and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Pleural and Pulmonary Diseases
  • Cardiac Imaging and Diagnostics
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Diagnosis and treatment of tuberculosis
  • Asthma and respiratory diseases
  • Infective Endocarditis Diagnosis and Management
  • Restraint-Related Deaths
  • Coronary Interventions and Diagnostics
  • Poisoning and overdose treatments
  • Cardiovascular Function and Risk Factors
  • Opioid Use Disorder Treatment
  • Tracheal and airway disorders
  • Cardiac Valve Diseases and Treatments
  • Acute Myocardial Infarction Research
  • Cardiac tumors and thrombi
  • Acute Ischemic Stroke Management
  • Respiratory Support and Mechanisms
  • Aortic Disease and Treatment Approaches
  • Heart Failure Treatment and Management
  • Lung Cancer Diagnosis and Treatment
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Lymphoma Diagnosis and Treatment
  • Tuberculosis Research and Epidemiology

Northwestern Medicine
2024

King Hussein Cancer Center
2022-2024

Centegra Hospital McHenry
2024

Rosalind Franklin University of Medicine and Science
2024

Northwestern Memorial Hospital
2024

University of Jordan
2020

Naloxone, an opioid receptor antagonist, effectively reverses overdose and opioid-induced respiratory depression. A few side effects were reported after naloxone administration, including arrhythmia pulmonary edema. Although rare, naloxone-induced edema can be a severe sometimes life-threatening complication requiring mechanical ventilation. This condition is predominantly linked to upsurge in catecholamines reversal as part of acute withdrawal syndrome, especially seen patients who...

10.1177/00185787241230074 article EN Hospital Pharmacy 2024-02-15

Background: A majority of patients included in risk assessment models (RAMs) developed to predict venous thromboembolic events (VTE) lymphoma were non-Hodgkin lymphoma. Our study aims evaluate the incidence and predictors VTE, utilizing different RAMs, with classic Hodgkin (cHL) treated adriamycin, bleomycin, vinblastine, dacarbazine (ABVD). Methods: Adult cHL, followed at our center, included. Correlations between variables, Khorana score, thrombosis (ThroLy) RAMs VTE examined using...

10.3390/jcm13020436 article EN Journal of Clinical Medicine 2024-01-12

Mediastinal masses present a diagnostic challenge due to their similar imaging characteristics, making distinguishing between noninfectious and infectious processes or malignancies difficult. A mediastinal abscess can result in severe life-threatening infections if left untreated. Traditional treatment approaches involve surgical debridement drainage; however, emerging endobronchial techniques, such as ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), offer less-invasive means...

10.1177/23247096241235534 article EN cc-by Journal of Investigative Medicine High Impact Case Reports 2024-01-01

The pathophysiology of coronary artery ectasia (CAE) is under investigated and not well understood. Atherosclerosis considered as the main etiologic factor for CAE in adults where more than 50% patients have atherosclerosis. Recently, lipoprotein (a) (Lp(a)) has emerged a powerful risk atherosclerosis disease (CAD). Serum levels Lp(a) with been investigated. We assumed that may play role pathogenesis CAE. Principally, our study aims to identify whether an independent CAE.Our prospective...

10.14740/cr992 article EN Cardiology Research 2020-01-01

Introduction: Despite that trastuzumab (TZB) improves life expectancy and prognosis in patients with HER-2 positive breast cancer (BC), cardiotoxicity is a well-established complication. However, other potential cardiac complications of TZB such as pulmonary hypertension (PHTN) are poorly investigated. Aim: Evaluate the effect on artery systolic pressure (PASP) measure predictors developing elevated PASP. Methods: The medical records for all females who received treatment confirmed BC at...

10.1161/circ.146.suppl_1.14248 article EN Circulation 2022-11-08
Coming Soon ...